Neurology Specific Literature Search   
 
[home][thesaurus]
    
Click Here to return To Results

 

Alemtuzumab CARE-MS II 5-year follow-up
Neurol 89:1117-1126, Coles, A.J.,et al, 2017
See this aricle in Pubmed

Article Abstract
Alemtuzumab provides durable efficacy through 5 years in patients with an inadequate response to prior therapy in the absence of continuous treatment.
 
Related Tags
(click to filter results - removes previous filter)

alemtuzumab
brain atrophy
efficacy
immunomodulation
monoclonal antibodies
MRI,abnormal
multiple sclerosis
multiple sclerosis,relapsing
multiple sclerosis,treatment of
safety
treatment of neurologic disorder

Click Here to return To Results